Irinotecan+S-1, repeated every 3 weeks.

2 trials

Sponsors

KSCC, CPT-11/TS-1 study group

Conditions

Unresectable advanced/recurrent colorectal canceradvanced/recurrent colorectal cancer

Phase 1

A multicenter phase I/II study of irinotecan (CPT-11) and S-1 combination chemotherapy for metastatic colorectal cancer (CRC)

Active, not recruitingJPRN-UMIN000001617

CPT-11/TS-1 study groupadvanced/recurrent colorectal cancer

Start: 2004-02-01Target: 30Updated: 2026-06-29

Phase 2

Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen

Active, not recruitingJPRN-UMIN000001342

KSCCUnresectable advanced/recurrent colorectal cancer

Start: 2007-08-03Target: 56Updated: 2026-06-29